Rapid Elimination of Culturable SARS-CoV-2 With Intramuscular or Intravenous Administration of Antiviral Monoclonal Antibody Therapy - Poll - MDSpire

Rapid Elimination of Culturable SARS-CoV-2 With Intramuscular or Intravenous Administration of Antiviral Monoclonal Antibody Therapy

  • By

  • Rinki Deo

  • Manish C Choudhary

  • Owen T Glover

  • Rachel Bender Ignacio

  • Julie Boucau

  • Kara W Chew

  • Carlee Moser

  • Judith S Currier

  • Joseph J Eron

  • Arzhang Cyrus Javan

  • Mark J Giganti

  • Evgenia Aga

  • Michael Gibbs

  • Taylor Cohen

  • Katie Streicher

  • Karina Soboleva

  • Courtney V Fletcher

  • Eric S Daar

  • Alexander L Greninger

  • Robert W Coombs

  • William Fischer

  • Michael D Hughes

  • Davey Smith

  • David Alain Wohl

  • Amy K Barczak

  • Jonathan Z Li

  • for the ACTIV-2/A5401 Study Team

  • September 8, 2025

  • 0 min

Share

Original Source(s)

Rapid Elimination of Culturable SARS-CoV-2 With Intramuscular or Intravenous Administration of Antiviral Monoclonal Antibody Therapy

  • by Rinki Deo, Manish C Choudhary, Owen T Glover, Rachel Bender Ignacio, Julie Boucau, Kara W Chew, Carlee Moser, Judith S Currier, Joseph J Eron, Arzhang Cyrus Javan, Mark J Giganti, Evgenia Aga, Michael Gibbs, Taylor Cohen, Katie Streicher, Karina Soboleva, Courtney V Fletcher, Eric S Daar, Alexander L Greninger, Robert W Coombs, William Fischer, Michael D Hughes, Davey Smith, David Alain Wohl, Amy K Barczak, Jonathan Z Li, for the ACTIV-2/A5401 Study Team

  • September 8, 2025

Related Content

Long COVID as a network disorder: a mechanism-anchored framework for biological stratification and therapeutic targeting

Effectiveness of Telemedicine vs Face-to-Face Consultation in Fighting COVID-19: Retrospective Cohort Study of Adult Patients With COVID-19 in a Primary Care Setting

Senate Report Details Early Myocarditis Signals After COVID-19 Vaccination

Investigative report cites internal communications, VAERS data, and CDC case reviews describing myocarditis and pericarditis reports in adolescents and young adults after mRNA COVID-19 vaccination.